Chemed Co. (NYSE:CHE) Shares Bought by Cwm LLC

Cwm LLC grew its stake in Chemed Co. (NYSE:CHE) by 22.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 485 shares of the company’s stock after buying an additional 88 shares during the period. Cwm LLC’s holdings in Chemed were worth $291,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of CHE. GAMMA Investing LLC grew its position in shares of Chemed by 34.4% during the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock worth $47,000 after acquiring an additional 22 shares during the last quarter. American National Bank & Trust purchased a new stake in Chemed during the third quarter worth about $61,000. Mather Group LLC. acquired a new stake in Chemed in the first quarter valued at $67,000. EntryPoint Capital LLC grew its position in shares of Chemed by 14.0% in the first quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock valued at $94,000 after purchasing an additional 18 shares during the last quarter. Finally, Quarry LP grew its holdings in Chemed by 721.7% during the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after buying an additional 166 shares during the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Chemed news, EVP Nicholas Michael Westfall sold 2,000 shares of the stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total transaction of $1,123,160.00. Following the transaction, the executive vice president now owns 5,990 shares of the company’s stock, valued at $3,363,864.20. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. In other Chemed news, Director George J. Walsh III sold 400 shares of the business’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $597.47, for a total transaction of $238,988.00. Following the completion of the sale, the director now owns 3,046 shares of the company’s stock, valued at approximately $1,819,893.62. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Nicholas Michael Westfall sold 2,000 shares of the business’s stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total value of $1,123,160.00. Following the sale, the executive vice president now owns 5,990 shares of the company’s stock, valued at $3,363,864.20. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 9,144 shares of company stock worth $5,264,839. 3.32% of the stock is owned by insiders.

Chemed Stock Down 1.6 %

NYSE CHE opened at $600.58 on Tuesday. Chemed Co. has a fifty-two week low of $502.64 and a fifty-two week high of $654.62. The business has a fifty day moving average of $584.35 and a 200-day moving average of $570.19. The stock has a market cap of $9.09 billion, a price-to-earnings ratio of 32.32, a price-to-earnings-growth ratio of 2.44 and a beta of 0.44.

Chemed (NYSE:CHE) last announced its earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share for the quarter, missing the consensus estimate of $5.59 by ($0.12). Chemed had a net margin of 12.88% and a return on equity of 29.21%. The firm had revenue of $595.88 million during the quarter, compared to analyst estimates of $599.20 million. During the same period in the previous year, the firm posted $4.71 EPS. The company’s revenue for the quarter was up 7.6% compared to the same quarter last year. As a group, analysts anticipate that Chemed Co. will post 21.77 EPS for the current year.

Chemed Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 12th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, August 12th. This represents a $2.00 dividend on an annualized basis and a yield of 0.33%. This is a positive change from Chemed’s previous quarterly dividend of $0.40. Chemed’s dividend payout ratio (DPR) is 10.76%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.